Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats.
Read More…
Industry, Sector and Symbol
Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
Phone843-740-2300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.13 billion
Profitability
Miscellaneous
Employees1,750
Next Earnings Date10/23/2019 (Confirmed)
OptionableOptionable
Ingevity (NYSE:NGVT) Frequently Asked Questions
What is Ingevity's stock symbol?
Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."
How were Ingevity's earnings last quarter?
Ingevity Corp (NYSE:NGVT) announced its quarterly earnings data on Wednesday, July, 24th. The company reported $1.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.35 by $0.01. The business had revenue of $352.80 million for the quarter, compared to the consensus estimate of $362.06 million. Ingevity had a net margin of 14.03% and a return on equity of 54.67%. Ingevity's quarterly revenue was up 14.3% on a year-over-year basis. During the same quarter last year, the company posted $1.12 earnings per share. View Ingevity's Earnings History.
When is Ingevity's next earnings date?
How can I listen to Ingevity's earnings call?
Ingevity will be holding an earnings conference call on Wednesday, October 23rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Ingevity issued on next quarter's earnings?
Ingevity updated its FY 2019 earnings guidance on Wednesday, July, 24th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.3-1.36 billion, compared to the consensus revenue estimate of $1.35 billion.
What price target have analysts set for NGVT?
7 brokerages have issued 12 month target prices for Ingevity's stock. Their predictions range from $99.00 to $130.00. On average, they expect Ingevity's stock price to reach $111.00 in the next twelve months. This suggests a possible upside of 32.3% from the stock's current price. View Analyst Price Targets for Ingevity.
What is the consensus analysts' recommendation for Ingevity?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity.
Has Ingevity been receiving favorable news coverage?
News coverage about NGVT stock has been trending very negative on Thursday, InfoTrie reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ingevity earned a daily sentiment score of -3.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Ingevity.
Are investors shorting Ingevity?
Ingevity saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 1,110,000 shares, an increase of 11.7% from the August 30th total of 993,300 shares. Based on an average trading volume of 323,700 shares, the days-to-cover ratio is currently 3.4 days. Currently, 2.7% of the company's stock are short sold. View Ingevity's Current Options Chain.
Who are some of Ingevity's key competitors?
Some companies that are related to Ingevity include FMC (FMC), Johnson Matthey (JMPLY), Huntsman (HUN), Ashland Global (ASH), W. R. Grace & Co (GRA), KURARAY CO LTD/ADR (KURRY), Univar (UNVR), Balchem (BCPC), Olin (OLN), Chemours (CC), Innospec (IOSP), PQ Group (PQG), GCP Applied Technologies (GCP), Livent (LTHM) and Innophos (IPHS).
What other stocks do shareholders of Ingevity own?
Who are Ingevity's key executives?
Ingevity's management team includes the folowing people:
- Mr. D. Michael Wilson, Pres, CEO & Director (Age 56)
- Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 52)
- Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 61)
- Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 53)
- Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 58)
Who are Ingevity's major shareholders?
Ingevity's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Copper Rock Capital Partners LLC (0.59%), Patten & Patten Inc. TN (0.41%), Gateway Investment Advisers LLC (0.04%), Pacer Advisors Inc. (0.04%), State of Alaska Department of Revenue (0.02%) and Fox Run Management L.L.C. (0.01%). Company insiders that own Ingevity stock include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Institutional Ownership Trends for Ingevity.
Which institutional investors are selling Ingevity stock?
NGVT stock was sold by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Gateway Investment Advisers LLC, Patten & Patten Inc. TN, Pacer Advisors Inc. and Crow Point Partners LLC. Company insiders that have sold Ingevity company stock in the last year include John C Fortson, Katherine Pryor Burgeson and Phillip John Platt. View Insider Buying and Selling for Ingevity.
Which institutional investors are buying Ingevity stock?
NGVT stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Fox Run Management L.L.C. and Valeo Financial Advisors LLC. View Insider Buying and Selling for Ingevity.
How do I buy shares of Ingevity?
Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Ingevity's stock price today?
One share of NGVT stock can currently be purchased for approximately $83.92.
How big of a company is Ingevity?
Ingevity has a market capitalization of $3.51 billion and generates $1.13 billion in revenue each year. The company earns $169.10 million in net income (profit) each year or $4.13 on an earnings per share basis. Ingevity employs 1,750 workers across the globe.View Additional Information About Ingevity.
What is Ingevity's official website?
How can I contact Ingevity?
Ingevity's mailing address is 5255 Virginia Avenue, North Charleston SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected]
MarketBeat Community Rating for Ingevity (NYSE NGVT)
MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
